(Source: MARKETWIRE)Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- One of the latest trendy phrases zipping around the Pharmaceutical Industry is "pharmerging markets." The phrase was coined to refer to the emerging world markets that are expected to experience double-digit growth, which, in turn, will unfortunately be offset by the lackluster performance predicted in established markets. The pharmerging areas are poised to receive the next major influx of capital activity from all of the Pharmaceutical Industry majors, e.g. Pfizer Incorporated (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK), Merck & Company Incorporated (NYSE:MRK), albeit with a definite risk of losing both intellectual and physical property.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=149279, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy related markets. For more than 26 years, Industrial Info has provided plant and project opportunity databases, market forecasts, high resolution maps, and daily industry news. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

 Contact: Joe Govreau 713-783-5147  

SOURCE: Industrial Info Resources

A service of YellowBrix, Inc.